Cardiac Rehabilitation in the Modern Era: Evidence, Equity, and Evolving Delivery Models Across the Cardiovascular

Anna S Mueller1, Samuel M Kim2

  • 1Department of Medicine, Mount Sinai Morningside/West, Icahn School of Medicine at Mount Sinai, New York, NY 10025, USA.

PubMed

Insights

Cardiac rehabilitation (CR) improves cardiovascular outcomes but is underutilized. This review highlights CR benefits, expands on its use in diverse populations, and discusses barriers and solutions to improve access and equity.

Area of Science:

  • Cardiovascular Medicine
  • Rehabilitation Science
  • Public Health

Background:

  • Cardiac rehabilitation (CR) is a vital secondary prevention strategy for cardiovascular disease (CVD), proven to reduce mortality and improve quality of life.
  • Despite strong evidence and guidelines, CR utilization remains suboptimal, especially among underrepresented groups like women, minorities, and older adults.
  • Existing disparities are exacerbated in low-resource settings, limiting access to life-saving interventions.

Purpose of the Study:

  • To review the comprehensive benefits of CR across various cardiovascular diseases.
  • To examine the expanding role of CR in newer patient populations, including heart failure with preserved ejection fraction (HFpEF) and post-transcatheter interventions.
  • To identify persistent barriers to CR access and participation and explore innovative solutions.

Main Methods:

  • Systematic review of current evidence on CR benefits and utilization.
  • Analysis of disease-specific outcomes and efficacy in diverse and expanding patient populations.
  • Examination of system-level and patient-level factors contributing to disparities in CR access.

Main Results:

  • CR demonstrates significant benefits in mortality reduction, hospital readmissions, functional capacity, and quality of life for CVD patients.
  • Emerging evidence supports CR's efficacy in HFpEF, older adults, advanced heart failure, and post-transcatheter procedures.
  • Key barriers include system/referral limitations and patient-level disparities related to age, sex, race, ethnicity, and socioeconomic status.

Conclusions:

  • CR is a cornerstone of cardiovascular secondary prevention with broad benefits, yet faces significant underutilization and access barriers.
  • Innovative delivery models and policy reforms are crucial for expanding equitable access to CR.
  • Continued investment and advocacy are necessary to ensure all eligible patients receive CR's life-saving benefits.

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
33
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
30
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
802
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
22
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
27